Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter!-Reference-Cited by-同舟云学术

Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter!

Published:2018-10-17 Issue: Volume:9 Page:
ISSN:1664-0640
Container-title:Frontiers in Psychiatry
language:
Short-container-title:Front. Psychiatry

Author:

Hengartner Michael P.,Plöderl Martin

Publisher

Frontiers Media SA

Subject

Psychiatry and Mental health

Reference60 articles.

1. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis;Cipriani;Lancet,2018

2. Pop a million happy pills? Antidepressants, nuance, and the media;Adlington;BMJ,2018

3. Methodological flaws, conflicts of interest, and scientific fallacies: Implications for the evaluation of antidepressants' efficacy and harm;Hengartner;Front Psychiatry,2017

4. Meta-analyses with industry involvement are massively published and report no caveats for antidepressants;Ebrahim;J Clin Epidemiol.,2016

5. Evidence b(i)ased medicine–selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications;Melander;BMJ,2003

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of mindfulness meditation on depressive symptoms during the COVID-19 pandemic: a systematic review and meta-analysis;Scientific Reports;2024-08-30

2. Sex-controlled differences in sertraline and citalopram efficacies in major depressive disorder: a randomized, double-blind trial;International Clinical Psychopharmacology;2024-04-18

3. Emerging pharmacotherapy for the treatment of cannabis use disorder;Expert Opinion on Pharmacotherapy;2024-04-12

4. Heterogeneity of outcome measures in depression trials and the relevance of the content of outcome measures to patients: a systematic review;The Lancet Psychiatry;2024-04

5. Ética en el uso de psicodélicos: la definición de las drogas ilícitas bajo la óptica de la bioética crítica;Salud Colectiva;2024-02-14